EluSys develops patent portfolio for antibody heteropolymers for treatment of cancer and infectious disease
Clients EluSys Therapeutics, Inc.
Jones Day managed the patent portfolio for EluSys Therapeutics, Inc. relating to antibody heteropolymers for treatment of cancer and infectious disease.